Atlas Trials

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

Clinical trial NCT04103034 · COMPLETED

Trial details

NCT number
NCT04103034
Sponsor
Band Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cerebrovascular StrokeLarge-Artery Atherosclerosis (Embolus/Thrombosis)Intracranial Arteriosclerosis
Start date
2019-10-07
Primary completion
2020-09-14
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.